Petersson, Maria. 2008. Opposite effects of oxytocin on proliferation of osteosarcoma cell lines. Regulatory Peptides, 150: 50-54.
Link to Article
Summary of Introduction and Methods
- induce wound healing
- weight gain
- higher birth weight babies when there is a high oxytocin level in the mother’s system
- increases growth factors
- contributes to blastocyst development, and cell proliferation
However, oxytocin can also inhibit proliferation of some cells such as breast cancer and brain tumor cells.
Markers such a as Osteocalcin occurs during late osteoblast differentiation, and ALP occurs in the early stages of osteoblast differentiation can help to determine if cell differentiation phase plays a role in the response of oxytocin to the cell. This experiment explores the effects of oxytocin on cell proliferation in two human osteosarcoma cell lines, SaOS-2, TE-85, and one rat osteosarcoma cell line, UMR-106. These cell lines have different stages of differentiation.
They determined the effects of oxytocin on cell proliferation by:
- Measuring DNA synthesis through thymidine incorporation
- Determined the amount of reduction of uncolored tetrazolium salts into formazon derivitives (which are intensely colored) using an EZ4U kit
- Growing the cells for 48-72 hours
- The cells were cultivated and then incubated with various concentrations of oxytocin, oxytocin antagonist, or oxytocin + oxytocin antagonist for 24 or 48 hours
- Results from the EZ4U kit were analyzed as means and standard deviation. ANOVA Tests and Fishers test were used for statistical analysis with P-values 0.05 or less considered significant
Summary of Main Results
SaOS-2
Figure 1: Proliferation of SaOS-2 cells compared to a control measured using EZ4U kit and thymidine incorporation in DNA synthesis when incubated for 24 hours with oxytocin or oxytocin and an antagonist.
Increased cell proliferation significantly determined by both tests (EZ4U and Thymidine incorporation). Concentrations of 100 pmol/l increased cell proliferation by 116-122% when compared to the control. When incubated with oxytocin antagonist there was no cell proliferation. Thus, this shows that SaOS-2 cells, which have differential stages of osteoblast differentiation (ALP and osteocalcin markers) experiences proliferation when under the influence of oxytocin.
TE-85
Figure 2: Proliferation of TE-85 cells compared to a control measured using EZ4U kit and thymidine incorporation in DNA synthesis when incubated for 24 hours with oxytocin or oxytocin and an antagonist.
Proliferation decreased to 81-83% of the control when incubated with oxytocin which was determined through both tests (EZ4U and Thymidine incorporation). These effects were lost when incubated with both oxytocin and oxytocin antagonist, yet the antagonist alone had no effect on cell proliferation. The most effective concentration for decrease was 08% 7.3% of the control. This data was considered statistically significant because p<0.05.>
Because oxytocin effects on both SaOS-2 and TE-85 cell lines were diminished upon addition of the oxytocin antagonist, it can be determined that oxytocin is acting through the oxytocin receptor. As well, past studies have shown that these same results on osteosarcoma cell lines in the presence of 17B-estradiol, which is understandable as estrogens increase the:
- synthesis of oxytocin
- the number of oxytocin receptors
- the binding of oxytocin receptors
UMR-106
Figure 3: Proliferation of UMR-106 cells compared to a control measured using EZ4U kit and thymidine incorporation in DNA synthesis when incubated for 24 hours with oxytocin, oxytocin antagonist, or oxytocin and an antagonist.
When incubated with oxytocin cell proliferation decreased to 80-82% of the control but when incubated with the oxytocin antagonist this decrease still occurred. Alone, the oxytocin decreased cell proliferation. UMR-106 cells are similar to human TE-85 cells because they have small amounts of ALP and no osteocalcin. However, when an antagonist was added cell proliferation was inhibited. This could be a result of:
- Different origin of species
- The antagoginst receptor having agonistic effects to the oxytocin receptor
Oxytocin may indeed play a large role in cell growth.
Other studies have illustrated that oxytocin has been shown to:
- Induce important autocrine effects in breast tumors
- Decrease a cytokine production that stimulates osteoclastogenesisIncrease prostaglandin
- E2 synthesis in osteoblast cells
- Increase plasma IGF-I levels in rats
- Acts as a mediator in IGF-I effects in the ovary
- Interact with Estradiol
How does the study relate?
Differentiation of these cells may contribute to the effect oxytocin has on cell proliferation. Through the study, it can now be theorized that oxytocin can influence proliferation of osteosarcoma cells. Thus, it may play a role in bone cancer and bone metastasis from other tissues.
Critique
Overall this paper was extremely straightforward and easy to follow. The use of real cell lines under simulated physiological conditions that represent a normal bodily state help to yield creditable results and a great protocol for future experiments involving oxytocin and the proliferation of cells. Thus, thymidine incorporation in DNA synthesis combined with an EZ4U kit can allow for a great analysis of cell growth and the influence that various factors, not only hormones, play on proliferation.
The figures were more then self explanatory, and ensured that every described result was displayed easily to the reader. The effects of oxytocin on cell proliferation of various cell line types were obvious and a quick connection relating different cell lines was possible.
The described steps required for the model were very useful at giving individuals who hope to use this protocol an expectation work and effort required to analyze how certain factors effect on cell proliferation.Unfortunately, the paper described that the figures represented "at least three separate experiments. Similar results were obtained in all experiments." If all results were similar, then there would be no need to exclude them from the means obtained to create the figures. Thus, the study becomes questionable as readers wonder if data was selected based on the most 'positive' results, rather then a random selection of 3 groups of data from the experiment. Thus, if the researchers would include all experimental data the exact results would be clearer and more accurate. It was also briefly stated that data for the oxytocin antagonist alone for both SaOS-2 and TE-85 cell lines played no effect on cell proliferation. It would not have taken much effort to include this data in the figures, thus the authors opinion on a proliferation effect may contribute to biased data.
Possible Future Experiments
This study leads to a huge amount of possible experiments that could generate useful data.
1. If other combinations of differential cell lines are located in tissues prone to cancer, then these tissues can be used based on cell differentiation and the effects that oxytocin plays in their proliferation.
2. Can oxytocin antagonists decrease cell proliferation of cells? Could localized treatment using antagonist result be used medically as a treatment for decreasing tumor growth?
3. Further validate this experiment by including more then three samples thus proving the accuracy of the described results of oxytocin on cell proliferation in osteosarcoma differentiated cell lines.